Clinical and laboratory profile, disease activity and outcome of childhood systemic lupus erythematosus - A retrospective study in a tertiary care hospital in Assam

Autor: Dhrubajyoti S, Kumar DP, Jolly D, Sreejana S, Meetei NM

Publikováno v: Journal of Medical and Scientific Research, Vol 12, Iss 3, Pp 195-201 (2024)

Background: Systemic lupus erythematosus in children (cSLE) represents 10-20% of all cases of SLE. However, this is still underreported from Assam. In this study, we report our experience with 25 patients of cSLE over the last 3.5 years. Materials

Externí odkaz: https://doaj.org/article/34ba02eb8daa40debe3196f106e54c19

Using Literary Texts in Developing Intercultural Competence of Foreign English Language Learners in Virtual Space.

Autor: Sharma, Vipin K., Kalapala, Kiran Kumar, Sreejana, S., S. V., Narasimha Murthy

Publikováno v: Arab World English Journal; 2023 Special Issue, p18-28, 11p

Egalitarian Worldview: The Fundamental Deliberation of Nature in the Poems of W. S. Merwin.

Autor: Mohanraj, S. G., Sreejana, S.

Publikováno v: Language in India; Jan2018, Vol. 18 Issue 1, p383-389, 6p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape.

Autor: Ghose A; Department of Medical Oncology, Barts Cancer Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Department of Medical Oncology, Medway NHS Foundation Trust, Kent, UK.; Department of Medical Oncology, Mount Vernon Cancer Centre, Mount Vernon and Watford NHS Trust, Watford, UK.; Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK.; Immuno-Oncology Clinical Network, London, UK.; The Meet-URO Group, Italian Network for Research in Uro-Oncology, Milan, Italy.; British Oncology Network for Undergraduate Societies, London, UK.; United Kingdom and Ireland Global Cancer Network, London, UK., Lapitan P; British Oncology Network for Undergraduate Societies, London, UK.; United Kingdom and Ireland Global Cancer Network, London, UK.; School of Medical Sciences, University of Manchester, Manchester, UK.; UCL Cancer Institute, University College London, London, UK.; Division of Genetics and Epidemiology, Institute of Cancer Research, Surrey, UK., Apte V; University College London Medical School, London, UK.; University College London Oncology Society, London, UK., Ghosh A; UCL Cancer Institute, University College London, London, UK., Kandala A; University College London Medical School, London, UK., Basu S; UCL Cancer Institute, University College London, London, UK.; University College London Oncology Society, London, UK., Parkes J; Immuno-Oncology Clinical Network, London, UK.; Worcestershire Oncology Centre, Worcestershire Acute Hospitals NHS Trust, Worcester, UK.; British Oncology Pharmacy Association, London, UK., Shinde SD; Cancer Academic Sciences Unit, University of Southampton, University Hospital Southampton NHS Foundation Trust, Southampton, UK., Boussios S; Department of Medical Oncology, Medway NHS Foundation Trust, Kent, UK.; School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.; Faculty of Medicine, Health and Social Care, Canterbury Christ Church University, Canterbury, UK.; Kent and Medway Medical School, University of Kent, Canterbury, UK.; AELIA Organisation, 9Th Km Thessaloniki - Thermi, 57001, Thessaloniki, Greece., Sharma A; Department of Medical Oncology, Mount Vernon Cancer Centre, Mount Vernon and Watford NHS Trust, Watford, UK.; Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK., Das P; Department of Oncology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.; School of Medicine, University of Nottingham, Nottingham, UK., Vasdev N; Hertfordshire and Bedfordshire Urological Cancer Centre, Department of Urology, Lister Hospital, East and North Herts NHS Trust, Stevenage, UK.; School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.; Apollo Hospitals Educational and Research Foundation (AHERF), Chennai, India., Rebuzzi SE; The Meet-URO Group, Italian Network for Research in Uro-Oncology, Milan, Italy.; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy.; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy., Ürün Y; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.; Ankara University Cancer Research Institute, Ankara, Turkey., Kanesvaran R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; Duke-NUS Medical School, SingHealth Duke-NUS Oncology Academic Clinical Programme, Singapore, Singapore., Maniam A; Department of Medical Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK. Akash.Maniam@porthosp.nhs.uk.; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK. Akash.Maniam@porthosp.nhs.uk.; Caribbean Cancer Research Institute, Port of Spain, Trinidad and Tobago. Akash.Maniam@porthosp.nhs.uk., Banna GL; The Meet-URO Group, Italian Network for Research in Uro-Oncology, Milan, Italy.; Department of Medical Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK.

Publikováno v: Current oncology reports [Curr Oncol Rep] 2024 Jun; Vol. 26 (6), pp. 633-646. Date of Electronic Publication: 2024 Apr 23.